Fulton Bank Increased Astrazeneca Plc (AZN) Stake; Mexico Equity & Income Fund Has 1 Sentiment

April 5, 2018 - By Martha Paddon

AstraZeneca PLC (NYSE:AZN) Logo

Fulton Bank increased Astrazeneca Plc (AZN) stake by 85.63% reported in 2017Q4 SEC filing. Fulton Bank acquired 36,750 shares as Astrazeneca Plc (AZN)’s stock rose 3.15%. The Fulton Bank holds 79,666 shares with $2.76M value, up from 42,916 last quarter. Astrazeneca Plc now has $87.76 billion valuation. It closed at $35.22 lastly. It is down 9.03% since April 5, 2017 and is uptrending. It has underperformed by 2.52% the S&P500.

Mexico Equity & Income Fund Inc (MXE) investors sentiment decreased to 1 in 2017 Q4. It’s down -0.33, from 1.33 in 2017Q3. The ratio dropped, as 8 active investment managers increased or opened new holdings, while 8 decreased and sold equity positions in Mexico Equity & Income Fund Inc. The active investment managers in our database now have: 4.30 million shares, up from 4.13 million shares in 2017Q3. Also, the number of active investment managers holding Mexico Equity & Income Fund Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 6 Increased: 6 New Position: 2.

Fulton Bank decreased Marathon Pete Corp (NYSE:MPC) stake by 6,157 shares to 15,685 valued at $1.04M in 2017Q4. It also reduced Ishares Tr (IWD) stake by 5,380 shares and now owns 152,379 shares. Harbor Fd (HAINX) was reduced too.

Among 26 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 17 have Buy rating, 0 Sell and 9 Hold. Therefore 65% are positive. AstraZeneca plc (ADR) has $50 highest and $32 lowest target. $40.14’s average target is 13.97% above currents $35.22 stock price. AstraZeneca plc (ADR) had 45 analyst reports since July 31, 2015 according to SRatingsIntel. On Monday, September 14 the stock rating was upgraded by Deutsche Bank to “Buy”. The firm has “Outperform” rating by Bernstein given on Friday, September 22. The stock of AstraZeneca PLC (NYSE:AZN) earned “Buy” rating by Swedbank on Friday, July 31. The rating was maintained by Leerink Swann on Tuesday, February 6 with “Market Perform”. The company was upgraded on Wednesday, September 2 by HSBC. The firm has “Overweight” rating given on Friday, December 29 by JP Morgan. Argus Research upgraded the stock to “Buy” rating in Monday, August 29 report. The rating was upgraded by Leerink Swann to “Outperform” on Friday, December 9. The rating was initiated by Piperjaffray on Friday, September 23 with “Overweight”. Liberum Capital downgraded the stock to “Hold” rating in Thursday, September 14 report.

The stock increased 2.00% or $0.22 during the last trading session, reaching $11.22. About 11,164 shares traded. Mexico Equity & Income Fund Inc. (MXE) has risen 1.31% since April 5, 2017 and is uptrending. It has underperformed by 10.24% the S&P500.

AstraZeneca PLC (NYSE:AZN) Ratings Chart